Boxer Capital Management, LLC
63 holdingsFiling period: 2026-06-30Current AUM: $1.17Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TNGX | Tango Therapeutics Inc | 10.88M | $340.0M | $241.4M | 20.66% | -- | 2026-06-30 |
| 2 | RVMD | Revolution Medicines Inc | 500.0K | $93.6M | $92.0M | 7.87% | -- | 2026-06-30 |
| 3 | ABVX | Abivax SA | 605.0K | $80.6M | $52.3M | 4.48% | +405.0K | 2026-06-30 |
| 4 | — | Uniqure NV | 1.50M | $69.2M | $69.2M | 5.93% | +841.3K | 2026-06-30 |
| 5 | KOD | Kodiak Sciences Inc | 1.48M | $57.6M | $132.4M | 11.33% | +116.6K | 2026-06-30 |
| 6 | KYMR | Kymera Therapeutics Inc | 429.1K | $49.2M | $49.3M | 4.22% | +100.0K | 2026-06-30 |
| 7 | DFTX | Definium Therapeutics Inc | 998.5K | $47.0M | $35.6M | 3.05% | +400.0K | 2026-06-30 |
| 8 | REPL | Replimune Group Inc | 3.98M | $44.1M | $49.7M | 4.25% | +2.81M | 2026-06-30 |
| 9 | CELC | Celcuity Inc | 416.5K | $43.6M | $27.4M | 2.35% | +191.5K | 2026-06-30 |
| 10 | QTTB | Q32 Bio Inc | 3.15M | $40.1M | $26.6M | 2.28% | -- | 2026-06-30 |
| 11 | CAPR | Capricor Therapeutics Inc | 1.40M | $33.6M | $8.0M | 0.69% | +805.2K | 2026-06-30 |
| 12 | PGEN | Precigen Inc | 5.15M | $29.4M | $31.1M | 2.66% | +1.65M | 2026-06-30 |
| 13 | CORT | Corcept Therapeutics Inc | 335.5K | $29.2M | $29.2M | 2.50% | +85.5K | 2026-06-30 |
| 14 | SRZN | Surrozen Inc. | 1.11M | $27.0M | $28.3M | 2.43% | +339.4K | 2026-06-30 |
| 15 | PTGX | Protagonist Therapeutics Inc | 170.0K | $20.8M | $23.9M | 2.04% | -- | 2026-06-30 |
| 16 | VIR | Vir Biotechnology Inc | 1.87M | $19.0M | $20.6M | 1.76% | -- | 2026-06-30 |
| 17 | PCVX | Vaxcyte Inc | 325.0K | $18.9M | $19.5M | 1.67% | -- | 2026-06-30 |
| 18 | — | Urogen Pharma Ltd | 500.0K | $18.4M | $18.4M | 1.57% | -- | 2026-06-30 |
| 19 | CRVS | Corvus Pharmaceuticals Inc | 1.10M | $16.4M | $11.5M | 0.98% | -- | 2026-06-30 |
| 20 | PTCT | Ptc Therapeutics Inc | 200.0K | $16.3M | $12.2M | 1.05% | -- | 2026-06-30 |
| 21 | PRAX | Praxis Precision Medicines I | 46.5K | $15.6M | $12.4M | 1.06% | -- | 2026-06-30 |
| 22 | AMLX | Amylyx Pharmaceuticals Inc | 800.0K | $14.4M | $21.7M | 1.85% | -- | 2026-06-30 |
| 23 | OCUL | Ocular Therapeutix Inc | 1.30M | $12.8M | $8.4M | 0.72% | +950.0K | 2026-06-30 |
| 24 | IRD | Opus Genetics Inc | 2.81M | $11.6M | $9.3M | 0.80% | +565.0K | 2026-06-30 |
| 25 | PALI | Palisade Bio Inc | 4.80M | $10.0M | $5.9M | 0.51% | -- | 2026-06-30 |
← Scroll →
Page 1 of 3